#Sweden #Gothenburg #Zinzino AB #Truvy #Bodē Pro

Zinzino AB Reports Strong Financial Results for Q3 2025

GOTHENBURG, Sweden, Nov. 19, 2025 — Zinzino AB (publ.), a leading health and wellness company, has disclosed its interim report for the third quarter of 2025, revealing remarkable financial growth marked by significant revenue increases and expanding profit margins. The company reported a quarterly revenue of SEK 784.1 million, representing a substantial 47% increase compared to SEK 532.8 million reported in the same quarter last year.

With a local currency growth rate of 53%, Zinzino's performance exemplifies a consolidating trend driven by both strategic business acquisitions and the rising demand for its products. The effective integration of recent acquisitions has fortified its market position, particularly in North America and various regions including Latin America and Japan.

Revenue Growth and Profit Margins

In the third quarter, Zinzino reported:

• - Total Revenue: SEK 784.1 million (Q3 2024: SEK 532.8 million)
• - Gross Profit: SEK 277.2 million, enhancing the gross profit margin to 35.4%
• - EBITDA: Increased to SEK 109.7 million from SEK 63.0 million, with the EBITDA margin improving to 14.0%
• - Net Profit: SEK 89.4 million compared to SEK 42.6 million for Q3 2024
• - Net Earnings per Share: SEK 2.47 (previous year: SEK 1.24)
• - Operating Cash Flow: SEK 136.6 million, significantly up from SEK 36.9 million

The growth in EBITDA margin has been chiefly attributed to a stronger gross profit and increased operational synergies stemming from the acquisition of Zurvita. This maneuver significantly contributed to Zinzino's capacity to deliver robust financial performance amid a competitive market environment.

Strategic Acquisitions

During the quarter, Zinzino expanded its distribution capabilities by acquiring the assets from two US-based direct sales firms, Bodē Pro and Truvy. This acquisition aligns with Zinzino's strategic goal to enhance its reach in the dynamic and crucial North American market, bolstering their operations not just in the US, but extending influence into Latin America, South Korea, and Japan.

In the broader financial landscape, Zinzino's total revenue for the nine-month period of January to September stood at SEK 2,302.2 million – reflecting an impressive growth of 54% compared to SEK 1,494.3 million from the same period last year. The gross profit over this period reached SEK 748.7 million, with a slight decrease in gross profit margin to 32.5%. Nonetheless, a noteworthy EBITDA of SEK 268.2 million signifies sustained operational effectiveness.

Looking Ahead

The company maintains a robust balance sheet, ending the reporting period with SEK 529.2 million in cash and cash equivalents. As Zinzino continues to forge ahead, recent strategic moves, including the acquisition of Sanki and a proposed investment in Xion International Group, are expected to bolster its innovative capabilities in the health sector, particularly focusing on omega-3 oil and spirulina.

In closing, Zinzino's proactive measures and phenomenal growth in the third quarter of 2025 highlight its dedicated approach to delivering health solutions and fortifying its market presence through intelligent acquisitions and strategic developments. This growth trajectory signals a strong commitment to profitability, innovation, and sustainability in today's health-conscious environment.

More detailed information can be accessed via Zinzino's official report. For investor inquiries, the company’s CEO, Dag Bergheim Pettersen, can be reached at +47 (0) 932 25 700.